Anna Ridderstad Wollberg

RISE:Research Institutes of Sweden, Focus Area Manager New Therapies, Senior Project Manager. 

Leading collaboration projects with external partners and other initiatives to gear up for future needs. New Therapies addresses new formulations and delivery systems for traditional drugs and biological pharmaceuticals, as well as advanced therapy medicinal products (ATMP) in combination with precision medicine for more individualized treatments.

Previous positions

2012-2018, Project Manager at Uppsala BIO

National project leader ofSwelifecalls and the open innovation programmes BIO-X, and IndustrialPartnership; scouting and coaching projects and point of contact to industrial partner.

1999-2012: Different roles at AstraZeneca R&D Södertälje; Associate Principal Scientist, Project leader; small molecule and biological projects 

1998-1999: Post Doc at CGR, Karolinska Institutet

1995-1997: Post Doc at The Walter and Eliza Hall Institute of Medical Research (WEHI), Melbourne, Australia

1994: PhD ImmunologyStockholm University 

Research fields

Immunology, autoimmunity and inflammation; MS, analgesia and Alzheimer’s disease; academic and industrial research. Target validation, in vivo models, ex vivo analyses, translational science.